All Stories

  1. Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir - A prospective study

    Article • Journal of Viral Hepatitis, October 2018, Wiley

    Prof Henry LY Chan, Renny chan

  2. Improvements in the management of chronic hepatitis B virus infection

    Article • Expert Review of Gastroenterology & Hepatology, October 2018, Taylor & Francis

    Prof Henry LY Chan

  3. Editorial: a baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients-same score, different outcomes. Author's Reply

    Article • Alimentary Pharmacology & Therapeutics, October 2018, Wiley

    Prof Henry LY Chan

  4. Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B

    Article • Liver International, September 2018, Wiley

    Prof Henry LY Chan

  5. Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment

    Article • Alimentary Pharmacology & Therapeutics, August 2018, Wiley

    Prof Henry LY Chan

  6. Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong

    Article • Liver International, July 2018, Wiley

    Prof Henry LY Chan

  7. Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014

    Article • Journal of Gastroenterology and Hepatology, July 2018, Wiley

    Prof Henry LY Chan

  8. A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, June 2018, Wiley

    Prof Henry LY Chan

  9. Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness

    Article • Journal of Gastroenterology and Hepatology, June 2018, Wiley

    Prof Henry LY Chan

  10. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment

    Article • Journal of Gastroenterology and Hepatology, January 2018, Wiley

    Clinical Chair Professor Henning Gronbaek, Prof Henry LY Chan

  11. Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory-wide cohort study

    Article • Journal of Gastroenterology and Hepatology, January 2018, Wiley

    Prof Henry LY Chan

  12. The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C

    Article • Liver International, January 2018, Wiley

    Prof Henry LY Chan, Man-Fung Yuen

  13. Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, January 2018, Wiley

    Prof Henry LY Chan, Man-Fung Yuen

  14. The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups

    Article • Journal of Gastroenterology and Hepatology, December 2017, Wiley

    Prof Henry LY Chan

  15. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

    Article • Journal of Gastroenterology and Hepatology, December 2017, Wiley

    Prof Henry LY Chan

  16. Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia

    Article • Journal of Viral Hepatitis, November 2017, Wiley

    Prof Henry LY Chan

  17. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4

    Article • Journal of Viral Hepatitis, November 2017, Wiley

    Prof Henry LY Chan

  18. Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis

    Article • Alimentary Pharmacology & Therapeutics, September 2017, Wiley

    Prof Henry LY Chan

  19. A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trial

    Article • Liver International, September 2017, Wiley

    Prof Henry LY Chan

  20. Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

    Article • Alimentary Pharmacology & Therapeutics, July 2017, Wiley

    Prof Henry LY Chan, Fabio Marra

  21. Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease

    Article • Journal of Gastroenterology and Hepatology, June 2017, Wiley

    Prof Henry LY Chan

  22. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population

    Article • Alimentary Pharmacology & Therapeutics, June 2017, Wiley

    Prof Henry LY Chan

  23. Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong

    Article • Journal of Gastroenterology and Hepatology, May 2017, Wiley

    Prof Henry LY Chan, Grace Lui, Vincent Wong

  24. Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease

    Article • Alimentary Pharmacology & Therapeutics, May 2017, Wiley

    Prof Henry LY Chan

  25. The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B

    Article • Hepatology, April 2017, Wiley

    Professor Thomas Berg, Prof Henry LY Chan, Dr Mangia Alessandra

  26. A Cost-effectiveness Analysis for Viral Hepatitis C Treatment in Hong Kong

    Article • Journal of Gastroenterology and Hepatology, April 2017, Wiley

    Prof Henry LY Chan

  27. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B

    Article • Journal of Gastroenterology and Hepatology, March 2017, Wiley

    Prof Henry LY Chan

  28. Long-term use of oral nucleos(t)ide analogues for chronic hepatitis B does not increase cancer risk - a cohort study of 44 494 subjects

    Article • Alimentary Pharmacology & Therapeutics, February 2017, Wiley

    Prof Henry LY Chan

  29. A New Indication of Fibroscan Before Liver Surgery

    Article • Journal of Gastroenterology and Hepatology, February 2017, Wiley

    Prof Henry LY Chan

  30. A new biomarker for hepatitis B

    Article • Journal of Hepatology, February 2017, Elsevier

    Prof Henry LY Chan

  31. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values

    Article • Hepatology, November 2016, Wiley

    Prof Henry LY Chan, Fabio Marra

  32. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, September 2016, Wiley

    Prof Henry LY Chan

  33. Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma

    Article • Liver International, August 2016, Wiley

    Prof Henry LY Chan

  34. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients

    Article • Hepatology, July 2016, Wiley

    Prof Henry LY Chan

  35. Reply

    Article • Hepatology, May 2016, Wiley

    Prof Henry LY Chan

  36. Virus and Host Testing to Manage Chronic Hepatitis B

    Article • Clinical Infectious Diseases, May 2016, Oxford University Press (OUP)

    Prof Henry LY Chan

  37. Reply

    Article • Gastroenterology, May 2016, Elsevier

    Prof Henry LY Chan

  38. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease

    Article • Journal of Gastroenterology and Hepatology, April 2016, Wiley

    Prof Henry LY Chan

  39. Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B

    Article • Gut, January 2016, BMJ

    Prof Henry LY Chan

  40. Infection and Cancer: The Case of Hepatitis B

    Article • Journal of Clinical Oncology, January 2016, American Society of Clinical Oncology (ASCO)

    Prof Henry LY Chan

  41. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study

    Article • Hepatology, December 2015, Wiley

    Prof Henry LY Chan

  42. Reply

    Article • Hepatology, December 2015, Wiley

    Prof Henry LY Chan

  43. Chronic kidney disease: Treatment of hepatitis C virus infection in patients with CKD

    Article • Nature Reviews Nephrology, November 2015, Nature

    Prof Henry LY Chan

  44. Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, November 2015, Wiley

    Prof Henry LY Chan

  45. Letter: association between moderate alcohol consumption and non-alcoholic fatty liver disease - authors’ reply

    Article • Alimentary Pharmacology & Therapeutics, October 2015, Wiley

    Prof Henry LY Chan

  46. Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong Kong

    Article • Alimentary Pharmacology & Therapeutics, October 2015, Wiley

    Prof Henry LY Chan

  47. Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy

    Article • PLoS ONE, September 2015, PLOS

    Prof Henry LY Chan

  48. Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent

    Article • Antiviral Research, September 2015, Elsevier

    Prof Henry LY Chan

  49. Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects

    Article • Hepatology, July 2015, Wiley

    Prof Henry LY Chan

  50. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy

    Article • The American Journal of Gastroenterology, July 2015, Nature

    Prof Henry LY Chan

  51. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score

    Article • Journal of Gastroenterology and Hepatology, July 2015, Wiley

    Prof Henry LY Chan

  52. Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study

    Article • Alimentary Pharmacology & Therapeutics, July 2015, Wiley

    Prof Henry LY Chan

  53. Higher Estimated Net Endogenous Acid Production May Be Associated with Increased Prevalence of Nonalcoholic Fatty Liver Disease in Chinese Adults in Hong Kong

    Article • PLoS ONE, April 2015, PLOS

    Prof Henry LY Chan

  54. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

    Article • Gut, April 2015, BMJ

    Prof Henry LY Chan

  55. Adverse Effects of Vitamin D Deficiency on Outcomes of Patients With Chronic Hepatitis B

    Article • Clinical Gastroenterology and Hepatology, April 2015, Elsevier

    Prof Henry LY Chan

  56. Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, March 2015, Wiley

    Prof Henry LY Chan

  57. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection

    Article • Annals of Surgical Oncology, March 2015, Springer Science + Business Media

    Prof Henry LY Chan

  58. Letter: pre- and post-operative anti-viral therapy is important for patients with hepatitis B virus-related hepatocellular carcinoma - authors’ reply

    Article • Alimentary Pharmacology & Therapeutics, March 2015, Wiley

    Prof Henry LY Chan

  59. Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease

    Article • Hepatology International, March 2015, Springer Science + Business Media

    Prof Henry LY Chan

  60. Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B

    Article • Journal of Gastroenterology and Hepatology, February 2015, Wiley

    Prof Henry LY Chan

  61. Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients

    Article • Digestive Diseases and Sciences, January 2015, Springer Science + Business Media

    Prof Henry LY Chan

  62. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index for Hepatocellular Carcinoma

    Article • Disease Markers, January 2015, Hindawi Publishing Corporation

    Prof Henry LY Chan

  63. Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy

    Article • Journal of Hepatology, January 2015, Elsevier

    Prof Henry LY Chan

  64. Hepatitis B virus infection

    Article • The Lancet, December 2014, Elsevier

    Prof Henry LY Chan

  65. Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study

    Article • Alimentary Pharmacology & Therapeutics, November 2014, Wiley

    Prof Henry LY Chan

  66. Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B

    Article • Journal of Viral Hepatitis, November 2014, Wiley

    Prof Henry LY Chan

  67. Liver Injury Is Common Among Chronic Abusers of Ketamine

    Article • Clinical Gastroenterology and Hepatology, October 2014, Elsevier

    Prof Henry LY Chan

  68. Abstract 5134: Histone deacetylase 8 is a novel chromatin modulator in NAFLD-associated hepatocarcinogenesis

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Prof Henry LY Chan

  69. Reply

    Article • Hepatology, September 2014, Wolters Kluwer Health

    Prof Henry LY Chan, Vincent Wong

  70. Editorial: metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B - authors' reply

    Article • Alimentary Pharmacology & Therapeutics, September 2014, Wiley

    Prof Henry LY Chan

  71. Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

    Article • Infectious Diseases and Therapy, September 2014, Springer Science + Business Media

    Prof Henry LY Chan

  72. A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B

    Article • Clinical Infectious Diseases, September 2014, Oxford University Press (OUP)

    Prof Henry LY Chan

  73. Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

    Article • Gut, May 2014, BMJ

    Prof Henry LY Chan

  74. Sa1482 Clinical Outcomes in Hepatocellular Carcinoma Patients With Esophageal Variceal Bleeding Managed With Endoscopic Band Ligation or Cyanoacrylate Injection

    Article • Gastrointestinal Endoscopy, May 2014, Elsevier

    Prof Henry LY Chan

  75. Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA

    Article • Gastroenterology, May 2014, Elsevier

    Prof Henry LY Chan

  76. Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication

    Article • Histopathology, March 2014, Wiley

    Prof Henry LY Chan

  77. Commentary: how long does one need to fast before a Fibroscan examination?

    Article • Alimentary Pharmacology & Therapeutics, February 2014, Wiley

    Prof Henry LY Chan

  78. Fatty Pancreas, Insulin Resistance, and β-Cell Function: A Population Study Using Fat-Water Magnetic Resonance Imaging

    Article • The American Journal of Gastroenterology, February 2014, Nature

    Prof Henry LY Chan

  79. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B

    Article • Journal of Hepatology, February 2014, Elsevier

    Prof Henry LY Chan

  80. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease

    Article • Seminars in Cancer Biology, December 2013, Elsevier

    Prof Henry LY Chan

  81. Quantitative Elastography of Liver Fibrosis and Spleen Stiffness in Chronic Hepatitis B Carriers: Comparison of Shear-Wave Elastography and Transient Elastography with Liver Biopsy Correlation

    Article • Radiology, December 2013, Radiological Society of North America (RSNA)

    Prof Henry LY Chan

  82. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: A prospective cohort study with paired transient elastography examination

    Article • Journal of Gastroenterology and Hepatology, November 2013, Wiley

    Prof Henry LY Chan

  83. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, November 2013, Wiley

    Prof Henry LY Chan

  84. Quantitative Elastography of Liver Fibrosis and Spleen Stiffness in Chronic Hepatitis B Carriers: Comparison of Shear-Wave Elastography and Transient Elastography with Liver Biopsy Correlation

    Article • Radiology, October 2013, Radiological Society of North America (RSNA)

    Prof Henry LY Chan

  85. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: A prospective cohort study with paired transient elastography examination

    Article • Journal of Gastroenterology and Hepatology, October 2013, Wiley

    Prof Henry LY Chan

  86. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

    Article • Hepatology, September 2013, Wiley

    Prof Henry LY Chan

  87. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial

    Article • Journal of Hepatology, September 2013, Elsevier

    Prof Henry LY Chan

  88. Chronic Hepatitis B: A Treatment Update

    Article • Seminars in Liver Disease, August 2013, Thieme Publishing Group

    Prof Henry LY Chan

  89. Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels

    Article • Hepatology, July 2013, Wiley

    Prof Henry LY Chan

  90. Chronic Hepatitis B: A Treatment Update

    Article • Seminars in Liver Disease, June 2013, Thieme Publishing Group

    Prof Henry LY Chan

  91. Liver Stiffness Measurement by Transient Elastography as a Predictor on Posthepatectomy Outcomes

    Article • Annals of Surgery, May 2013, Wolters Kluwer Health

    Prof Henry LY Chan

  92. Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment

    Article • Gastroenterology, May 2013, Elsevier

    Prof Henry LY Chan

  93. 773 SERUM HEPATITIS B SURFACE ANTIGEN LEVELS TO GUIDE THE CESSATION OF ENTECAVIR IN HEPATITIS B e ANTIGEN-NEGATIVE CHRONIC HEPATITIS B: AN INTERIM ANALYSIS

    Article • Journal of Hepatology, April 2013, Elsevier

    Prof Henry LY Chan

  94. 101 TENOFOVIR DF (TDF) COMPARED TO EMTRICITABINE (FTC)/TDF IN HBeAg-POSITIVE, CHRONIC HEPATITIS B (CHB) VIRUSINFECTED PATIENTS IN THE IMMUNE TOLERANT (IT) PHASE

    Article • Journal of Hepatology, April 2013, Elsevier

    Prof Henry LY Chan

  95. Non-Invasive Methods to Determine the Severity of NAFLD and NASH

    Article • March 2013, Wiley

    Prof Henry LY Chan

  96. Association Between Anthropometric Parameters and Measurements of Liver Stiffness by Transient Elastography

    Article • Clinical Gastroenterology and Hepatology, March 2013, Elsevier

    Prof Henry LY Chan

  97. Use of quantitative hepatitis B surface antigen with hepatitis B virus DNA in clinical practice

    Article • Clinical Liver Disease, February 2013, Wiley

    Prof Henry LY Chan

  98. Efficacy of entecavir switch therapy in chronic hepatitis B patients with incomplete virological response to telbivudine

    Article • Antiviral Therapy, January 2013, International Medical Press

    Prof Henry LY Chan

  99. Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis e antigen negative chronic hepatitis B patients receiving nucleos(t)ide analogues

    Article • Antiviral Therapy, January 2013, International Medical Press

    Prof Henry LY Chan

  100. Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

    Article • Journal of Viral Hepatitis, December 2012, Wiley

    Prof Henry LY Chan

  101. Treatment of non‐alcoholic steatohepatitis with Phyllanthus urinaria: A randomized trial

    Article • Journal of Gastroenterology and Hepatology, December 2012, Wiley

    Prof Henry LY Chan

  102. Hepatitis B virus reactivation associated with anti-neoplastic therapy

    Article • Journal of Gastroenterology and Hepatology, December 2012, Wiley

    Prof Henry LY Chan

  103. Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

    Article • The American Journal of Gastroenterology, October 2012, Nature

    Prof Henry LY Chan

  104. Peginterferon therapy for chronic hepatitis B: one size fits all?

    Article • Gut, September 2012, BMJ

    Prof Henry LY Chan

  105. Are we ready to use the hepatitis B surface antigen level to guide peginterferon treatment in HBeAg-negative chronic hepatitis B?

    Article • Hepatology International, June 2012, Springer Science + Business Media

    Prof Henry LY Chan

  106. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

    Article • Journal of Hepatology, June 2012, Elsevier

    Prof Henry LY Chan

  107. Identifying Hepatitis B Carriers at Low Risk for Hepatocellular Carcinoma

    Article • Gastroenterology, May 2012, Elsevier

    Prof Henry LY Chan

  108. 936 Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis by Combined Serum Biomarkers

    Article • Gastroenterology, May 2012, Elsevier

    Prof Henry LY Chan

  109. Tu1036 The Cirrhosis Risk Score is Not Associated With Liver Fibrosis/Cirrhosis and Fibrosis Progression in Chinese Non-Alcoholic Fatty Liver Disease Patients

    Article • Gastroenterology, May 2012, Elsevier

    Prof Henry LY Chan

  110. Mo1532 Predictors of Response to Entecavir in Chronic Hepatitis B Patients With Incomplete Virologic Response to Telbivudine in a Four-Year Prospective Cohort

    Article • Gastroenterology, May 2012, Elsevier

    Prof Henry LY Chan

  111. 460 IMPACT OF SEVERE HEPATITIS REACTIVATION ON THE KINETICS OF HEPATITIS B SURFACE ANTIGEN LEVELS IN HEPATITIS B E ANTIGEN (HBEAG)-NEGATIVE CHRONIC HEPATITIS B

    Article • Journal of Hepatology, April 2012, Elsevier

    Prof Henry LY Chan

  112. 504 EARLY ON-TREATMENT DECLINE OF SERUM HEPATITIS B SURFACE ANTIGEN (HBSAG) IS ASSOCIATED WITH FASTER SUBSEQUENT HBSAG REDUCTION IN HBEAG-NEGATIVE CHRONIC HEPATITIS B

    Article • Journal of Hepatology, April 2012, Elsevier

    Prof Henry LY Chan

  113. Hepatitis B virus infection and fatty liver in the general population

    Article • Journal of Hepatology, March 2012, Elsevier

    Prof Henry LY Chan

  114. Response-guided therapy by hepatitis B surface antigen level for peginterferon therapy: What is next?

    Article • Journal of Gastroenterology and Hepatology, February 2012, Wiley

    Prof Henry LY Chan

  115. Hepatitis B

    Article • January 2012, Elsevier

    Prof Henry LY Chan

  116. Direkter Vergleich der Hepatitis B Viruskinetik während 12 Wochen mit Telbivudine (LDT) vs. Tenofovir (TDF) vs. Kombination LDT und TDF bei Patienten mit chronischer Hepatitis B

    Article • Seminars in Musculoskeletal Radiology, January 2012, Thieme Publishing Group

    Prof Henry LY Chan

  117. 606: Maternal HBeAg status and hepatitis B viral activity in HBsAg positive mothers

    Article • American Journal of Obstetrics and Gynecology, January 2012, Elsevier

    Prof Henry LY Chan

  118. Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinoma

    Article • Liver International, August 2011, Wiley

    Prof Henry LY Chan

  119. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir

    Article • Alimentary Pharmacology & Therapeutics, August 2011, Wiley

    Prof Henry LY Chan

  120. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

    Article • Gut, August 2011, BMJ

    Prof Henry LY Chan

  121. Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?

    Article • Journal of Hepatology, August 2011, Elsevier

    Prof Henry LY Chan

  122. The G1613A Mutation in the HBV Genome Affects HBeAg Expression and Viral Replication through Altered Core Promoter Activity

    Article • PLoS ONE, July 2011, PLOS

    Prof Henry LY Chan

  123. Antiviral Drug Resistance Testing in Patients with Chronic Hepatitis B

    Article • Digestive Diseases and Sciences, July 2011, Springer Science + Business Media

    Prof Henry LY Chan

  124. Viral Determinants of Hepatitis B Surface Antigen Seroclearance in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients

    Article • The Journal of Infectious Diseases, July 2011, Oxford University Press (OUP)

    Prof Henry LY Chan

  125. Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy

    Article • Alimentary Pharmacology & Therapeutics, June 2011, Wiley

    Prof Henry LY Chan

  126. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

    Article • The Lancet Oncology, June 2011, Elsevier

    Prof Henry LY Chan

  127. Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test?

    Article • Journal of Gastroenterology and Hepatology, February 2011, Wiley

    Prof Henry LY Chan

  128. Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B

    Article • Journal of Hepatology, February 2011, Elsevier

    Prof Henry LY Chan

  129. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010

    Article • Journal of Digestive Diseases, January 2011, Wiley

    Prof Henry LY Chan

  130. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients

    Article • Antiviral Therapy, January 2011, International Medical Press

    Prof Henry LY Chan

  131. Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients

    Article • Antiviral Therapy, January 2011, International Medical Press

    Prof Henry LY Chan

  132. Chronic hepatitis B in Asia-new insights from the past decade

    Article • Journal of Gastroenterology and Hepatology, January 2011, Wiley

    Prof Henry LY Chan

  133. Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in Asia

    Article • Journal of Gastroenterology and Hepatology, December 2010, Wiley

    Prof Henry LY Chan

  134. Rate and Factors Affecting Treatment Uptake of Patients with Chronic Hepatitis C in a Tertiary Referral Hospital

    Article • Digestive Diseases and Sciences, October 2010, Springer Science + Business Media

    Prof Henry LY Chan

  135. Letters to the Editors: Potential pitfalls on the validation of liver stiffness measurement by Fibroscan with histological staging in chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, September 2010, Wiley

    Prof Henry LY Chan

  136. Meta-analysis: reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, August 2010, Wiley

    Prof Henry LY Chan

  137. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B

    Article • Hepatology, July 2010, Wiley

    Prof Henry LY Chan

  138. Transient elastography

    Article • Journal of Gastroenterology and Hepatology, July 2010, Wiley

    Prof Henry LY Chan

  139. Individualisation of antiviral therapy for chronic hepatitis C

    Article • Journal of Gastroenterology and Hepatology, June 2010, Wiley

    Prof Henry LY Chan

  140. Antiviral Therapy for Acute-on-Chronic Liver Failure in Chronic Hepatitis B: Is It Too Late?

    Article • Digestive Diseases and Sciences, May 2010, Springer Science + Business Media

    Prof Henry LY Chan

  141. W1894 Elucidating Gene Regulatory Network of COOH-Terminal Truncated Hbx Associated With Hepatocellular Carcinoma

    Article • Gastroenterology, May 2010, Elsevier

    Prof Henry LY Chan

  142. A magnetic bead-based serum proteomic fingerprinting method for parallel analytical analysis and micropreparative purification

    Article • Electrophoresis, April 2010, Wiley

    Prof Henry LY Chan

  143. 394 ON-TREATMENT MONITORING OF LIVER FIBROSIS WITH TRANSIENT ELASTOGRAPHY IN CHRONIC HEPATITIS B

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof Henry LY Chan

  144. 1031 DURABILITY OF PEGINTERFERON ALFA-2B TREATMENT BEYOND 5 YEARS IN PATIENTS WITH HEPATITIS B E ANTIGEN (HBEAG) POSITIVE CHRONIC HEPATITIS B

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof Henry LY Chan

  145. 560 OBSTETRIC HISTORY AND THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN FEMALE CHRONIC HEPATITIS B CARRIERS

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof Henry LY Chan

  146. Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

    Article • Journal of Clinical Oncology, April 2010, American Society of Clinical Oncology (ASCO)

    Prof Henry LY Chan

  147. 723 A SIMPLE BREATH TEST CAN ASSESS LIVER FUNCTION AND PREDICT CLINICAL OUTCOME IN CHRONIC HEPATITIS B

    Article • Journal of Hepatology, April 2010, Elsevier

    Prof Henry LY Chan

  148. Authors' response

    Article • Gut, March 2010, BMJ

    Prof Henry LY Chan

  149. Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

    Article • Hepatology, February 2010, Wiley

    Prof Henry LY Chan

  150. Metabolic syndrome and chronic hepatitis B: is the evidence enough?

    Article • Gut, February 2010, BMJ

    Prof Henry LY Chan

  151. Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy

    Article • Journal of Clinical Virology, February 2010, Elsevier

    Prof Henry LY Chan

  152. Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed?

    Article • Antiviral Therapy, January 2010, International Medical Press

    Prof Henry LY Chan

  153. Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy

    Article • Antiviral Therapy, January 2010, International Medical Press

    Prof Henry LY Chan

  154. Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

    Article • Journal of Hepatology, December 2009, Elsevier

    Prof Henry LY Chan

  155. Hepatitis B Virus Genotype C Is Associated With More Severe Liver Fibrosis Than Genotype B

    Article • Clinical Gastroenterology and Hepatology, December 2009, Elsevier

    Prof Henry LY Chan

  156. Predictors of Treatment Response in Chronic Hepatitis B

    Article • Drugs, November 2009, Springer Science + Business Media

    Prof Henry LY Chan

  157. Interaction of Adipokines and Hepatitis B Virus on Histological Liver Injury in the Chinese

    Article • The American Journal of Gastroenterology, October 2009, Nature

    Prof Henry LY Chan

  158. Reply:

    Article • Hepatology, October 2009, Wiley

    Prof Henry LY Chan

  159. Surrogate End Points and Long-Term Outcome in Patients With Chronic Hepatitis B

    Article • Clinical Gastroenterology and Hepatology, October 2009, Elsevier

    Prof Henry LY Chan

  160. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

    Article • Hepatology, September 2009, Wiley

    Prof Henry LY Chan

  161. 6516 A scoring system in predicting the risk of hepatocellular carcinoma in chronic hepatitis B carrier

    Article • European Journal of Cancer Supplements, September 2009, Elsevier

    Prof Henry LY Chan

  162. High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome

    Article • Journal of Virological Methods, August 2009, Elsevier

    Prof Henry LY Chan

  163. CS15-01 Can We Prevent Hepatocellular Carcinoma in Chronic Hepatitis B?

    Article • International Journal of Infectious Diseases, August 2009, Elsevier

    Prof Henry LY Chan

  164. High Incidence of Mortality and Recurrent Bleeding in Patients With Helicobacter pylori–Negative Idiopathic Bleeding Ulcers

    Article • Gastroenterology, August 2009, Elsevier

    Prof Henry LY Chan

  165. Severe acute exacerbation of chronic hepatitis B: A unique presentation of a common disease

    Article • Journal of Gastroenterology and Hepatology, July 2009, Wiley

    Prof Henry LY Chan

  166. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B

    Article • International Journal of Cancer, June 2009, Wiley

    Prof Henry LY Chan

  167. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B

    Article • Journal of Gastroenterology and Hepatology, June 2009, Wiley

    Prof Henry LY Chan

  168. Interferon-induced thyroid dysfunction-not always transient

    Article • Journal of Gastroenterology and Hepatology, June 2009, Wiley

    Prof Henry LY Chan

  169. S1596 Serum N-Glycomic Fingerprinting Is Useful in the Diagnosis of Liver Fibrosis and Liver Cirrhosis in Patients with Chronic Hepatitis B Infection Before and After Antiviral Treatment

    Article • Gastroenterology, May 2009, Elsevier

    Prof Henry LY Chan

  170. 691 The Role of PPARγ Modulation in the Growth Inhibition of Hepatocellular Carcinoma Cells

    Article • Gastroenterology, May 2009, Elsevier

    Prof Henry LY Chan

  171. Treatment of chronic hepatitis B: focus on telbivudine

    Article • Expert Review of Anti-infective Therapy, April 2009, Informa Healthcare

    Prof Henry LY Chan

  172. 350 CLINICAL FACTORS PREDICTING ADVANCED LIVER FIBROSIS IN HEPATITIS B E ANTIGEN POSITIVE CHRONIC HEPATITIS B

    Article • Journal of Hepatology, April 2009, Elsevier

    Prof Henry LY Chan

  173. 235 LONG-TERM FOLLOW-UP OF PATIENTS WITH HISTOLOGICAL RESPONSE TO CHRONIC HEPATITIS B TREATMENT

    Article • Journal of Hepatology, April 2009, Elsevier

    Prof Henry LY Chan

  174. Clinical Factors Associated With Liver Stiffness in Hepatitis B e Antigen–Positive Chronic Hepatitis B Patients

    Article • Clinical Gastroenterology and Hepatology, February 2009, Elsevier

    Prof Henry LY Chan

  175. Evaluation of Model for End Stage Liver Disease (MELD)-based systems as prognostic index for hepatocellular carcinoma

    Article • Journal of Gastroenterology and Hepatology, January 2009, Wiley

    Prof Henry LY Chan

  176. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

    Article • Journal of Viral Hepatitis, January 2009, Wiley

    Prof Henry LY Chan

  177. Efficacy of Cap-Assisted Colonoscopy in Comparison With Regular Colonoscopy: A Randomized Controlled Trial

    Article • The American Journal of Gastroenterology, January 2009, Nature

    Prof Henry LY Chan

  178. Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

    Article • Journal of Clinical Oncology, December 2008, American Society of Clinical Oncology (ASCO)

    Professor Paul KS Chan, Prof Henry LY Chan

  179. Evaluation of Alanine Transaminase and Hepatitis B Virus DNA to Predict Liver Cirrhosis in Hepatitis B e Antigen-Negative Chronic Hepatitis B Using Transient Elastography

    Article • The American Journal of Gastroenterology, December 2008, Nature

    Prof Henry LY Chan

  180. Revisiting the treatment recommendations for chronic hepatitis B

    Article • Hepatology, November 2008, Wiley

    Prof Henry LY Chan

  181. I-64 Viral factors of hepatocellular carcinoma in chronic hepatitis B

    Article • International Journal of Infectious Diseases, November 2008, Elsevier

    Prof Henry LY Chan

  182. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

    Article • Gut, October 2008, BMJ

    Prof Henry LY Chan

  183. A review of telbivudine for the management of chronic hepatitis B virus infection

    Article • Expert Opinion on Drug Metabolism & Toxicology, September 2008, Informa Healthcare

    Prof Henry LY Chan

  184. Assessment of Fibrosis by Transient Elastography Compared With Liver Biopsy and Morphometry in Chronic Liver Diseases

    Article • Clinical Gastroenterology and Hepatology, September 2008, Elsevier

    Prof Henry LY Chan

  185. Early Hepatitis B Virus DNA Suppression Can Predict Virologic Response to Peginterferon and Lamivudine Treatment

    Article • Clinical Gastroenterology and Hepatology, September 2008, Elsevier

    Prof Henry LY Chan

  186. A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China

    Article • Journal of Viral Hepatitis, June 2008, Wiley

    Prof Henry LY Chan

  187. Validation of the NAFLD Fibrosis Score in a Chinese Population With Low Prevalence of Advanced Fibrosis

    Article • The American Journal of Gastroenterology, June 2008, Nature

    Prof Henry LY Chan

  188. Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people

    Article • Journal of Gastroenterology and Hepatology, June 2008, Wiley

    Prof Henry LY Chan

  189. Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study

    Article • Gastrointestinal Endoscopy, April 2008, Elsevier

    Prof Henry LY Chan

  190. A Randomized Controlled Study Comparing Cap-Assisted Colonoscopy Versus Conventional Colonoscopy: The Final Result

    Article • Gastrointestinal Endoscopy, April 2008, Elsevier

    Prof Henry LY Chan

  191. Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: Identification of 17 novel mutations and its genetic heterogeneity

    Article • Journal of Human Genetics, March 2008, Nature

    Prof Henry LY Chan

  192. High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma

    Article • Journal of Clinical Oncology, January 2008, American Society of Clinical Oncology (ASCO)

    Prof Henry LY Chan

  193. 409 TREATMENT OF HEPATITIS B INFECTION REDUCES RISK OF HEPATO-CELLULAR CARCINOMA: A META-ANALYSIS

    Article • Journal of Hepatology, January 2008, Elsevier

    Prof Henry LY Chan

  194. Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir

    Article • Annals of Internal Medicine, December 2007, American College of Physicians

    Prof Henry LY Chan, Thierry Poynard

  195. Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response

    Article • Clinical Gastroenterology and Hepatology, December 2007, Elsevier

    Prof Henry LY Chan

  196. Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: Identification of 17 novel mutations and its genetic heterogeneity

    Article • Journal of Human Genetics, November 2007, Nature

    Prof Henry LY Chan

  197. RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma

    Article • Cancer Letters, August 2007, Elsevier

    Prof Henry LY Chan

  198. [489] SERUM HEPATITIS B SURFACE ANTIGEN (HBsAg) LEVEL CAN REFLECT HEPATITIS B VIRUS IN THE LIVER AND PREDICT TREATMENT RESPONSE

    Article • Journal of Hepatology, April 2007, Elsevier

    Prof Henry LY Chan

  199. [484] VALIDATION OF THE NEW MELD-Na SCORE IN PREDICTING LONG-TERM SURVIVAL IN PATIENTS WITH CHRONIC HEPATITIS B

    Article • Journal of Hepatology, April 2007, Elsevier

    Prof Henry LY Chan

  200. Obesity Is Associated With Increased Transient Lower Esophageal Sphincter Relaxation

    Article • Gastroenterology, March 2007, Elsevier

    Prof Henry LY Chan

  201. Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, February 2007, Wiley

    Prof Henry LY Chan

  202. Response to Drs. Navaneethan and Jayanthi

    Article • The American Journal of Gastroenterology, February 2007, Nature

    Prof Henry LY Chan

  203. Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C

    Article • Hepatology, January 2007, Wiley

    Prof Henry LY Chan

  204. Hepatocellular Carcinoma and Hepatitis B Virus

    Article • Seminars in Liver Disease, May 2006, Thieme Publishing Group

    Prof Henry LY Chan

  205. A Randomized Controlled Study Comparing Cap-Assisted Colonoscopy Versus Conventional Colonoscopy: A Preliminary Result

    Article • Gastrointestinal Endoscopy, April 2006, Elsevier

    Prof Henry LY Chan

  206. The Molecular Diagnosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma

    Article • Critical Reviews in Clinical Laboratory Sciences, January 2006, Taylor & Francis

    Prof Henry LY Chan

  207. Antiviral effect ofPhyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis

    Article • Journal of Cellular Biochemistry, January 2006, Wiley

    Prof Henry LY Chan

  208. Effect of celecoxib on experimental liver fibrosis in rat

    Article • Liver International, November 2005, Wiley

    Prof Henry LY Chan

  209. Reply to Liu and Kao

    Article • The Journal of Infectious Diseases, October 2005, Oxford University Press (OUP)

    Prof Henry LY Chan

  210. A Retrospective Study on Clinical Features and Prognostic Factors of Biopsy-Proven Primary Biliary Cirrhosis in Chinese Patients

    Article • The American Journal of Gastroenterology, October 2005, Nature

    Prof Henry LY Chan

  211. Pegylated Interferon-α2b and Lamivudine in Hepatitis B e Antigen-Positive Chronic Hepatitis B

    Article • Annals of Internal Medicine, September 2005, American College of Physicians

    Prof Henry LY Chan

  212. A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patients

    Article • Complementary Therapies in Medicine, September 2005, Elsevier

    Prof Henry LY Chan

  213. Transmission of hepatitis B by human bite—Confirmation by detection of virus in saliva and full genome sequencing

    Article • Journal of Clinical Virology, July 2005, Elsevier

    Professor Paul KS Chan, Prof Henry LY Chan

  214. Long-term Outcome of Helicobacter pylori–Negative Idiopathic Bleeding Ulcers: A Prospective Cohort Study

    Article • Gastroenterology, June 2005, Elsevier

    Prof Henry LY Chan

  215. Identification of Chronic Hepatitis B Patients without Significant Liver Fibrosis by a Simple Noninvasive Predictive Model

    Article • The American Journal of Gastroenterology, March 2005, Nature

    Prof Henry LY Chan

  216. A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone

    Article • Annals of Internal Medicine, February 2005, American College of Physicians

    Prof Henry LY Chan

  217. Molecular virology and drug resistance in antiviral therapy of chronic hepatitis B

    Article • Current Hepatology Reports, February 2005, Springer Science + Business Media

    Prof Henry LY Chan

  218. Clinical significance of hepatic derangement in severe acute respiratory syndrome

    Article • World Journal of Gastroenterology, January 2005, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Paul KS Chan, Prof Henry LY Chan

  219. Molecular virology in chronic hepatitis B: genotypes

    Article • British Journal of Hospital Medicine, January 2005, Mark Allen Group

    Prof Henry LY Chan

  220. Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, November 2004, Elsevier

    Prof Henry LY Chan

  221. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma

    Article • Gut, October 2004, BMJ

    Prof Henry LY Chan

  222. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2

    Article • Modern Pathology, June 2004, Nature

    Prof Henry LY Chan

  223. Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis

    Article • Clinical Transplantation, June 2004, Wiley

    Prof Henry LY Chan

  224. Retrospective analysis of liver function derangement in severe acute respiratory syndrome

    Article • The American Journal of Medicine, April 2004, Elsevier

    Professor Paul KS Chan, Prof Henry LY Chan

  225. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma

    Article • International Journal of Oncology, April 2004, Spandidos Publications

    Prof Henry LY Chan

  226. Use of Hepatitis B Virus DNA Quantitation To Predict Hepatitis B e Antigen Reversion in Cases of Chronic Hepatitis B

    Article • Journal of Clinical Microbiology, October 2003, ASM Journals

    Prof Henry LY Chan

  227. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection1 1The authors thank Man-yee Yung, Sara Fung, Dr. Bonnie Kwan, and Dr. Thomas Li for their help in retrieving patient information.

    Article • Gastroenterology, October 2003, Elsevier

    Professor Paul KS Chan, Prof Henry LY Chan

  228. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection

    Article • Gastroenterology, October 2003, Elsevier

    Prof Henry LY Chan

  229. Fatal outcome of SARS in a patient with reactivation of chronic hepatitis B

    Article • The American Journal of Medicine, September 2003, Elsevier

    Professor Paul KS Chan, Prof Henry LY Chan

  230. Adoptive immune transfer in liver transplantation of HBV-related liver diseases

    Article • Hepatology, May 2003, Wiley

    Prof Henry LY Chan

  231. A cirrhotic patient with fever and abdominal pain in the presence of ascites

    Article • Hospital Medicine, May 2003, Mark Allen Group

    Prof Henry LY Chan

  232. Persistently positive hepatitis B E antigen is associated with increased risk of hepatocellular carcinoma

    Article • Journal of Hepatology, April 2003, Elsevier

    Prof Henry LY Chan

  233. Hepatitis B Virus Genotype C Takes a More Aggressive Disease Course Than Hepatitis B Virus Genotype B in Hepatitis B e Antigen-Positive Patients

    Article • Journal of Clinical Microbiology, March 2003, ASM Journals

    Prof Henry LY Chan

  234. High incidence of incidental hepatocellular carcinoma exists among hepatitic explanted livers

    Article • Transplantation Proceedings, February 2003, Elsevier

    Prof Henry LY Chan

  235. Virological and histological outcome of a patient with chronic hepatitis B transplanted with liver from hepatitis C virus–positive donor

    Article • Transplantation Proceedings, February 2003, Elsevier

    Prof Henry LY Chan

  236. Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment

    Article • World Journal of Gastroenterology, January 2003, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof Henry LY Chan

  237. The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice

    Article • Journal of Viral Hepatitis, November 2002, Wiley

    Prof Henry LY Chan

  238. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong

    Article • The American Journal of Gastroenterology, October 2002, Nature

    Prof Henry LY Chan

  239. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong

    Article • The American Journal of Gastroenterology, October 2002, Nature

    Prof Henry LY Chan

  240. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation

    Article • Journal of Medical Virology, August 2002, Wiley

    Prof Henry LY Chan

  241. Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation

    Article • Journal of Clinical Gastroenterology, May 2002, Wolters Kluwer Health

    Prof Henry LY Chan

  242. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection

    Article • The American Journal of Gastroenterology, May 2002, Nature

    Prof Henry LY Chan

  243. Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients

    Article • Journal of Viral Hepatitis, May 2002, Wiley

    Prof Henry LY Chan

  244. Is it safe to stop lamivudine after the emergence of YMDD mutants during lamivudine therapy for chronic hepatitis B?

    Article • Journal of Hepatology, April 2002, Elsevier

    Prof Henry LY Chan

  245. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection

    Article • The American Journal of Gastroenterology, February 2002, Nature

    Prof Henry LY Chan

  246. Changing scene in hepatitis B serology interpretation

    Article • Hospital Medicine, January 2002, Mark Allen Group

    Prof Henry LY Chan

  247. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

    Article • The Lancet, January 2002, Elsevier

    Prof Henry LY Chan

  248. Hepatitis B virus reactivation during cytotoxic chemotherapy‐enhanced viral replication precedes overt hepatitis

    Article • Journal of Medical Virology, November 2001, Wiley

    Professor Paul KS Chan, Prof Henry LY Chan

  249. A double-blinded randomized comparison of celecoxib verusus omeprazole and diclofenac for secondary prevention of ulcer bleeding in chronic NSAID users

    Article • Gastroenterology, April 2001, Elsevier

    Prof Henry LY Chan

  250. Heartburn and acid regurgitation are unreliable diagnostic indicators of gastroesophageal reflux disease (GERD) in population with high prevalence of H. pylori infection

    Article • Gastroenterology, April 2001, Elsevier

    Prof Henry LY Chan

  251. Thymosin-α1 for the treatment of chronic hepatitis B virus (HBV) infection: A meta-analysis

    Article • Gastroenterology, April 2001, Elsevier

    Prof Henry LY Chan

  252. A meta-analysis of thymosin-a1 treatment in chronic hepatitis B virus (HBV) infection

    Article • Journal of Hepatology, April 2001, Elsevier

    Prof Henry LY Chan

  253. Thymosin-α1 for the treatment of chronic hepatitis B virus (HBV) infection: A meta-analysis

    Article • Gastroenterology, April 2001, Elsevier

    Prof Henry LY Chan

  254. A meta-analysis of thymosin-A1 treatment in chronic hepatitis B virus (HBV) infection

    Article • Journal of Hepatology, April 2001, Elsevier

    Prof Henry LY Chan

  255. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients

    Article • Gastrointestinal Endoscopy, April 2001, Elsevier

    Prof Henry LY Chan

  256. Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis

    Article • Journal of Medical Virology, January 2001, Wiley

    Prof Henry LY Chan

  257. Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus–infected patients

    Article • The American Journal of Gastroenterology, December 2000, Nature

    Prof Henry LY Chan

  258. Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus-infected patients

    Article • The American Journal of Gastroenterology, December 2000, Nature

    Prof Henry LY Chan

  259. Prognostic factors of survival at two years after onset of hepatic decompensation in chinese cirrhotic patients and the implications for liver transplantations

    Article • Gastroenterology, April 2000, Elsevier

    Prof Henry LY Chan

  260. Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapies

    Article • Gastroenterology, April 2000, Elsevier

    Prof Henry LY Chan

  261. Hepatitis B e antigen-negative chronic hepatitis b in Hong Kong

    Article • Hepatology, March 2000, Wiley

    Prof Henry LY Chan

  262. Occult hepatitis B virus (HBV) infection in cryptogenic liver cirrhosis

    Article • Journal of Hepatology, January 2000, Elsevier

    Prof Henry LY Chan

  263. HEPATITIS B IN ADULTS

    Article • Clinics in Liver Disease, May 1999, Elsevier

    Prof Henry LY Chan

  264. Different hepatitis b virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

    Article • Hepatology, March 1999, Wiley

    Prof Henry LY Chan

  265. Tissue injury of Injection Gold Probe

    Article • Gastrointestinal Endoscopy, September 1998, Elsevier

    Prof Henry LY Chan

  266. Different HBV genotypes are associated with different mutations in the core promoter and precore regions during HBeAg seroconversion

    Article • Gastroenterology, April 1998, Elsevier

    Prof Henry LY Chan

  267. Tissue injury of injection gold probe

    Article • Gastrointestinal Endoscopy, April 1997, Elsevier

    Prof Henry LY Chan

  268. Neurotoxicity following the ingestion of a Chinese medicinal plant, Alocasia macrorrhiza

    Article • Human & Experimental Toxicology, September 1995, SAGE Publications

    Prof Henry LY Chan